Comparative Pharmacokinetics and Pharmacodynamics of Synthetic Nicotine

Recruiting Phase 1 Interventional Study
Nicotine Dependence Nicotine Vaping
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
21 – 65
Sex
Any
Trial phase
Phase 1
Study type
Interventional
Purpose
Basic Science
Participants needed
18 (estimated)
Sponsor
University of California, San Francisco · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

In a crossover study, experienced electronic cigarette users will vape 3 different forms of nicotine: natural (derived from tobacco), synthetic, or a 50:50 mixture of both natural and synthetic. The investigators will compare nicotine metabolism, cardiovascular effects, patterns of self-administration, and participants' feelings of craving/withdrawal and enjoyment.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Healthy on the basis of medical history and limited physical examination. * Current regular user of E-Cigarettes (≥ 15 days in the past 30 days) Exclusion Criteria: * • Medications * Use of medications that are inducers of nicotine metabolizing enzyme CYP2A6 (Example: rif…
Contacts

Lisa Lawrence

628-206-4204

lisa.lawrence@ucsf.edu

CONTACT

Armando Barraza

510-560-4842

armando.barraza@ucsf.edu

CONTACT